ALGS Competitors & Alternatives
Compare Aligos Therapeutics, Inc. Common Stock with similar stocks in the same industry
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
ALGS
Main Stock$6.56
Tradestie Score
54
Market Cap
$71.53M
Revenue Growth
-0.7%
Analyst Upside
+903.0%
Top Competitors
170 stocks in BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
AMGN
Amgen Inc
|
$344.86
|
$160.70B | 24.6 | 55 | Compare |
|
GILD
Gilead Sciences Inc
|
$133.29
|
$137.92B | 20.0 | 48 | Compare |
|
ARGX
argenx SE American Depositary Shares
|
$805.38
|
$46.96B | 42.6 | 64 | Compare |
|
BNTX
BioNTech SE American Depositary Share
|
$111.60
|
$24.57B | - | 58 | Compare |
|
BIIB
Biogen Inc. Common Stock
|
$185.95
|
$22.61B | 20.9 | 63 | Compare |
|
NBIX
Neurocrine Biosciences Inc
|
$130.22
|
$13.59B | 28.2 | 64 | Compare |
|
EXEL
Exelixis Inc
|
$45.89
|
$11.09B | 15.7 | 66 | Compare |
|
MRNA
Moderna, Inc. Common Stock
|
$54.23
|
$10.74B | - | 58 | Compare |
|
QGEN
QIAGEN N.V.
|
$40.10
|
$10.04B | 20.1 | 55 | Compare |
|
TECH
Bio-Techne Corp.
|
$59.67
|
$9.33B | 114.3 | 53 | Compare |
More ALGS Analysis
Data updated: Apr 22, 2026 | Industry: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) (SIC 2836)
170 stocks in this industry